Login

Renren received a non-binding preliminary 'going private' offer from top executives at $4.20 per share in cash for each American depositary share. 00:10:00

Share On Facebook Share On Twitter

Joseph Chen and Chen Ji are the CEOs of Renren

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Philippe Brassac Discusses Crédit Agricole's Financial Performance and Economic Outlook | Philippe Brassac , CEO ,  Crédit Agricole SA .
00:10:00
Virgilio Bento's Journey to Unignorable Excellence | Vinod Khosla, Founder,  Khosla Ventures.
00:10:00
Mountain Province Diamonds: Current Operations and Industry Outlook
00:10:00
The former Engility president and CEO discusses Science Applications International Corp.'s international development service portfolio.
00:10:00
Talk by the fireside with Chin Hin Group Berhad | Yeoh Chin Hoe, CEO, Chin Hin Group BhdCHINHIN:KLS
00:10:00
Bridging the Gap with Small-Mid Value | William Blair Investment Management
00:10:00
Exploring Digital Assets: Insights from Brad Moines, CEO of Digitrade Financial Corporation
00:10:00
Exploring Innovative ETF Opportunities with John Porter | John Porter, CIO , Newton Investment Management .
00:10:00
The Crucial Role of BPMN for Business Analysts
00:10:00
With all of our stakeholders for your support and continued trust, Chenbro is able to grow constantly|CEO ,Chenbro Micom Co Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
Alight CEO Stephan Scholl appeared on CNBC's TechCheck from the New York Stock Exchange to discuss the cloud-based HR tech company's market.|Stephan Scholl, CEO of Alight Solutions,

© 2017 - Neuhu+